We are open as normal. As per NSW Health and best practice veterinary guidelines, we respectfully ask that on entering the hospital, you
We are continuing to offer contactless consults for anyone who prefers to be consulted outside, or does not have evidence of vaccination or where the clinician would like to see your pet outside, for example, to assess for lameness.
Contactless consultations are available if you would prefer to consult outside, you do not have evidence of vaccination, or you’ve been asked to stay in the carpark by a clinician. Clinicians may ask you to stay in the carpark if, for example, they want to see your pet exercise to assess for lameness.
When you arrive at SASH, please remain in your vehicle and call Client Services on (02) 9190 6805 or Tuggerah (02) 4044 1779.
We will then ask you to wait in your car with your pet while we notify the specialist of your arrival.
Please ensure you check in, and wear a mask.
When the specialist is ready to see your pet, a member of our SASH clinical team will come to your vehicle to collect your pet.
The Specialist will then come to your vehicle or call your mobile and talk you through the consultation.
Once the consultation is complete, we will advise if your pet needs further testing or hospital admission, or if they’re ready to come home with you.
After the consultation has been completed we will prepare your paperwork including any treatment plans or medication scripts.
We will then call you to arrange payment over the phone after which you will be reunited with your beloved pet.
Thousands of canine and feline specimens tested surfaced no positive results to date.
WESTBROOK, Maine, March 13, 2020—IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that the company has seen no positive results in pets to date of SARS-CoV-2, the coronavirus strain responsible for the coronavirus disease 2019 (COVID-19) respiratory outbreak in humans. IDEXX evaluated thousands of canine and feline specimens during validation of a new veterinary test system for the COVID-19 virus. The specimens used for test development and validation were obtained from specimens submitted to IDEXX Reference Laboratories for PCR testing.
These new test results align with the current expert understanding that COVID-19 is primarily transmitted person-to-person and supports the recommendation against testing pets for the COVID-19 virus. For dogs or cats presenting with respiratory signs, the recommendation is to contact a veterinarian to test for more common respiratory pathogens.
“Should leading health authorities determine it is clinically relevant to test pets for the COVID-19 virus, IDEXX will be ready to make the IDEXX SARS-CoV-2 (COVID-19) RealPCR™ Test available,” said Jay Mazelsky, President and Chief Executive Officer of IDEXX Laboratories. “Pets are important members of our family, and we want to keep them healthy and safe. We will continue to monitor COVID-19 and pet health across our global IDEXX Reference Laboratories network as this situation evolves.”
IDEXX Reference Laboratories is a global network of more than 80 laboratories united by a shared commitment to advancing pet care. IDEXX never stops looking for new ways to do more and discover more to enhance the health and well-being of pets, people, and livestock. Customers worldwide benefit from the company’s sophisticated network of veterinary reference laboratories in the United States, Canada, Australia, New Zealand, Japan, South Korea, South Africa, Brazil, and across Europe, which offer the most complete and advanced menu of tests in the industry.
For the most up-to-date information on the risk of COVID-19 virus transmission to animals and COVID-19 disease, please visit the U.S. Centers for Disease Control and Prevention, the American Veterinary Medical Association, or the World Organisation for Animal Health COVID-19 resource pages.
For additional resources from IDEXX, visit idexx.com/covid2019.
ARTICLE SOURCE: IDEXX